Publications by authors named "C Helissey"

Claim this Profile
G
Gastrointestinal metastasis in prostate cancer and therapeutic implications: A case report.
Marie-Anne Audisio, Anh-Tuan Nguyen, Evelyne Peroux, Jean-Laurent Lamboley, David Lussato, Carole Helissey

Oncol Lett· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-Generation Multicenter Studies: Using Artificial Intelligence to Automatically Process Unstructured Health Records of Patients with Lung Cancer across Multiple Institutions.
M Aldea, L Zullo, V Levrat, J Bennouna, S Schneider, C Helissey

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the Safety, Pharmacokinetics, and Antitumor Activity of Tusamitamab Ravtansine in Patients With Nonsquamous NSCLC With High or Moderate Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5.
Anas Gazzah, Charles Ricordel, Antoine Italiano, Byoung Chul Cho, Emiliano Calvo, Carole Helissey

JTO Clin Res Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and management of PARP inhibitor-related haematological toxicities in prostate cancer: French expert opinion using the Delphi method.
Ophélie Cassuto, Romain Mathieu, Carole Helissey, Antonin Schmitt, Aurélien Gobert

Ther Adv Med Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amivantamab Plus Lazertinib in Patients With EGFR-Mutant NSCLC After Progression on Osimertinib and Platinum-Based Chemotherapy: Results From CHRYSALIS-2 Cohort A.
Benjamin Besse, Koichi Goto, Yongsheng Wang, Se-Hoon Lee, Melina E Marmarelis, Carole Helissey

J Thorac Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis